{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:12:56Z","timestamp":1792624376558,"version":"4.5.0"},"reference-count":39,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s498848","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:25:12Z","timestamp":1740032712000},"page":"107-114","source":"Crossref","is-referenced-by-count":2,"title":["Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer Perspective"],"prefix":"10.2147","volume":"Volume 17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-4963","authenticated-orcid":true,"given":"Christian","family":"Siegfried","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuru","family":"Amarapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Fusfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2]]},"reference":[{"key":"ref1","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today. Accessed 16, July 2024."},{"key":"ref2","unstructured":"Multiple Myeloma Research Foundation [Internet]. Diagnostic testing for multiple myeloma. Available from: https:\/\/themmrf.org\/diagnosis-and-treatment\/diagnostic-testing\/. Accessed September 2024."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S1470-2045(24)00282-1","volume":"25","author":"Moreau","year":"2024","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMoa2312054","volume":"390","author":"Sonneveld","year":"2024","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1182\/blood.2022016170","volume":"140","author":"Paiva","year":"2022","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/jalm\/jfab055","volume":"6","author":"Kirchhoff","year":"2021","journal-title":"J Appl Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"932852","DOI":"10.3389\/fonc.2022.932852","volume":"12","author":"Ferla","year":"2022","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamaoncol.2016.3160","volume":"3","author":"Munshi","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref10","unstructured":"US Food & Drug Administration [Internet]. April 12, 2024 meeting of the oncologic drugs advisory committee meeting announcement. Available from: https:\/\/tinyurl.com\/2rexatkp. Accessed 16, July 2024."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1097\/HS9.0000000000000710","volume":"6","author":"Hibbs","year":"2022","journal-title":"Hemasphere"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0221534","DOI":"10.1371\/journal.pone.0221534","volume":"14","author":"Gendron","year":"2019","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pmn.2020.09.005","volume":"22","author":"Liptrott","year":"2021","journal-title":"Pain Manag Nurs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s12185-022-03364-2","volume":"115","author":"Murray","year":"2022","journal-title":"Int J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cca.2021.01.021","volume":"516","author":"Eveillard","year":"2021","journal-title":"Clin Chim Acta"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.clml.2019.09.239","volume":"19","author":"Berlanga","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"12446","DOI":"10.1182\/blood-2022-160249","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41408-021-00418-2","volume":"11","author":"Derman","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref19","volume-title":"WHO Regional Office for Europe on Behalf of the European Observatory on Health Systems and Policies","year":"2023"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1182\/blood-2021-151557","volume":"138","author":"Puig","year":"2021","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2204925","volume":"387","author":"Richardson","year":"2022","journal-title":"N Engl J Med"},{"key":"ref23","unstructured":"CIA. The World Factbook. Population of France. Available from: https:\/\/www.cia.gov\/the-world-factbook\/countries\/france\/. Accessed Feb 2024."},{"key":"ref24","unstructured":"Cancer research UK [Internet]. Survival statistics for myeloma. Available from: https:\/\/www.cancerresearchuk.org\/about-cancer\/myeloma\/survival. Accessed Feb 2024."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e306494f","DOI":"10.1097\/01.HS9.0000970656.30649.4f","volume":"7","author":"Hulin","year":"2023","journal-title":"Hemasphere"},{"key":"ref26","unstructured":"S\u00e9curit\u00e9 sociale, l\u2019Assurance maladie [Internet]. National biology coding table. Available from: http:\/\/www.codage.ext.cnamts.fr\/cgi\/nabm\/cgi-fiche?p_code_nabm=1571&p_date_jo_arrete=%25&p_menu=FICHE&p_site=AMELI. Accessed Feb 2024."},{"key":"ref27","unstructured":"Minist\u00e8re du Travail, de la Sant\u00e9 et des Solidarit\u00e9s. [Internet]. The repository of innovative procedures outside the biology and anatomopathology nomenclature (RIHN). Available from: https:\/\/sante.gouv.fr\/systeme-de-sante\/innovation-et-recherche\/rihn. Accessed Feb 2024."},{"key":"ref28","unstructured":"S\u00e9curit\u00e9 sociale, l\u2019Assurance Maladie [Internet]. Common classification of medical procedures (CCAM). Available from: https:\/\/www.ameli.fr\/accueil-de-la-ccam\/trouver-un-acte\/fiche-abregee.php?code=FEHB001. Accessed Feb 2024."},{"key":"ref29","unstructured":"Veranex primary research with 3 practicing Spanish hematologists in 2024."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-022-00772-9","volume":"13","author":"Mai","year":"2023","journal-title":"Blood Cancer J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.17195","volume":"193","author":"Abeykoon","year":"2021","journal-title":"Br J Haematol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3324\/haematol.2023.284662","volume":"109","author":"Szalat","year":"2024","journal-title":"Haematologica"},{"key":"ref33","unstructured":"International Myeloma Foundation. [Internet]. Bone marrow tests for multiple myeloma. Available from: www.myeloma.org. Accessed Dec 2024."},{"key":"ref34","unstructured":"Puig N, Agull\u00f3 C, Contreras T, et al. Combined mass spectrometry and next generation flow as early predictors of long-term response in relapsed\/refractory myeloma patients treated with CAR-T cells and T-cell engagers. EHA2024. Abstract#EHA\u20137107."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood.2021013794","volume":"139","author":"Giles","year":"2022","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e46491ff","DOI":"10.1097\/01.HS9.0000975320.46491.ff","volume":"7","author":"Berlanga","year":"2023","journal-title":"Hemasphere"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00277-020-03984-w","volume":"99","author":"Migkou","year":"2020","journal-title":"Ann Hematol"},{"key":"ref39","unstructured":"Veranex primary research with 5 practicing European hematologists in 2024."}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/100396","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/100396","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:25:19Z","timestamp":1740032719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/using-qip-ms-to-guide-the-timing-of-mrd-testing-in-patients-with-multi-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"URL":"https:\/\/doi.org\/10.2147\/ceor.s498848","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}